Business Today: JPMorgan results lift futures ahead of data

If you are having trouble viewing this email or would like to view it in your web browser, CLICK HERE

Good Morning Robert, THU 15 Jul 2010    JPMorgan results lift futures ahead of data Jobless claims fall to near 2-year low last week JPMorgan beats expectations as loan loss reserve cut Carlyle to buy supplements maker NBTY for $3.8 billion Vivus' weight-loss drug faces key U.S. test Wide investor audience awaits KKR Wall Street bill nears the finish line in Congress Glaxo takes $2.4 bln charge, Avandia mostly settled China economy cools in second quarter Apple on the defensive as earnings approach Asia shares weaker despite China GDP Japan auto woes rev up Retail's pressure to make the grade JPMorgan results lift futures ahead of data July 15, 2010 07:52 AM ET NEW YORK (Reuters) - Stock index futures were higher on Thursday after better-than-expected quarterly profits from JPMorgan Chase & Co allayed concerns about the strength of the financial sector. Full Article Jobless claims fall to near 2-year low last week July 15, 2010 08:36 AM ET WASHINGTON (Reuters) -New claims for unemployment insurance fell more than expected last week to their lowest level in nearly two years as seasonal layoffs eased at factories, government data showed on Thursday. Full Article JPMorgan beats expectations as loan loss reserve cut July 15, 2010 08:01 AM ET NEW YORK (Reuters) - JPMorgan Chase & Co posted higher second-quarter earnings on Thursday, beating analysts' expectations, after setting aside less money for loan losses. Full Article Carlyle to buy supplements maker NBTY for $3.8 billion July 15, 2010 07:47 AM ET BANGALORE (Reuters) - U.S. nutritional supplements maker NBTY Inc said it agreed to be bought by Carlyle Group for $3.8 billion in one of the biggest private equity deals so far this year. Full Article Vivus' weight-loss drug faces key U.S. test July 15, 2010 08:09 AM ET WASHINGTON (Reuters) - The first potential U.S. prescription weight-loss pill in more than a decade could move closer to market on Thursday if it can overcome safety hurdles that have plagued diet drugs for years and led to tepid sales despite the growing number of obese Americans. Full Article Wide investor audience awaits KKR July 15, 2010 07:46 AM ET NEW YORK/BOSTON (Reuters) - Kohlberg Kravis Roberts & Co's long-awaited listing on the Big Board brings a wide investor audience to the iconic private equity firm and could be a bellwether for rivals looking to follow suit. Full Article Wall Street bill nears the finish line in Congress July 15, 2010 05:39 AM ET WASHINGTON (Reuters) - The broadest overhaul of U.S. financial rules since the Great Depression is likely to clear a crucial hurdle in Congress on Thursday morning, paving the way for President Barack Obama to sign the measure into law. Full Article Glaxo takes $2.4 bln charge, Avandia mostly settled July 15, 2010 08:12 AM ET LONDON (Reuters) - GlaxoSmithKline expects to record a legal charge of 1.57 billion pounds ($2.4 billion) for the second quarter after settling the "substantial majority" of claims relating to its controversial diabetes pill Avandia. Full Article China economy cools in second quarter July 15, 2010 04:45 AM ET BEIJING (Reuters) - China's economy cooled in the second quarter, a slowdown that is likely to extend over the rest of the year as Beijing steers monetary and fiscal policy back to normal after a record credit surge to counter the global crisis. Full Article Apple on the defensive as earnings approach July 15, 2010 07:05 AM ET SAN FRANCISCO/NEW YORK (Reuters) - Apple Inc finds itself on unfamiliar ground heading into its earnings report next week: on the defensive. Full Article

REUTERS www.reuters.com Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book.Details Subscribe to other Reuters newsletters Unsubscribe from this newsletter. Send this mailing to a friend or colleague Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS | Interactive TV | Labs | Reuters in Second Life | Archive | Site Index | Video Index Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers